Top compounds associated with response to RP11-178C3.1


Feature Type Standardized
Nominal ANOVA
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.021 0.6
mRNA itraconazole CTRPv2 pan-cancer AAC -0.021 0.6
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.029 0.6
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.02 0.6
mRNA nakiterpiosin CTRPv2 pan-cancer AAC 0.018 0.6
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.6
mRNA NSC23766 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC -0.02 0.6
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.02 0.6
Download CSV